Literature DB >> 23116690

A systematic review finds prediction models for chronic kidney disease were poorly reported and often developed using inappropriate methods.

Gary S Collins1, Omar Omar, Milensu Shanyinde, Ly-Mee Yu.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is a global health concern that is increasing mainly as the result of increasing incidences of diabetes and hypertension. Furthermore, if left untreated, individuals with CKD may progress to end-stage kidney failure. Identifying individuals with undiagnosed CKD or those who are at an increased risk of developing CKD or progressing to end-stage kidney disease (ESKD) is therefore an important challenge. We sought to systematically review and critically assess the conduct and reporting of methods used to develop risk prediction models for predicting the risk of having undiagnosed (prevalent) or future risk of developing (incident) CKD or end-stage kidney failure in adults.
METHODS: We conducted a systematic search of PubMed database to identify studies published up until September 2011 that describe the development of models combining two or more variables to predict the risk of prevalent or incident CKD or ESKD. We extracted key information that describes aspects of developing a prediction model, including the study design, data quality, sample size and number of events, outcome definition, risk predictor selection and coding, missing data, model-building strategies, and aspects of performance.
RESULTS: Eleven studies describing the development of 14 prediction models were included. Eight studies reported the development of 11 models to predict incident CKD or ESKD, whereas 3 studies developed models for prevalent CKD. A total of 97 candidate risk predictors were considered, and 43 different risk predictors featured in the 14 prediction models. A method, not recommended to select risk predictors for inclusion in the multivariate model, using statistical significance from univariate screening was carried out in six studies. Missing data were frequently poorly handled and reported with no mention of missing data in four studies; 4 studies explicitly excluded individuals with missing data, and only 2 studies used multiple imputation to replace missing values.
CONCLUSION: We found that prediction models for chronic kidney were often developed using inappropriate methods and were generally poorly reported. Using poor methods can affect the predictive ability of the models, whereas inadequate reporting hinders an objective evaluation of the potential usefulness of the model.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23116690     DOI: 10.1016/j.jclinepi.2012.06.020

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  50 in total

1.  Applying the Temporal Abstraction Technique to the Prediction of Chronic Kidney Disease Progression.

Authors:  Li-Chen Cheng; Ya-Han Hu; Shr-Han Chiou
Journal:  J Med Syst       Date:  2017-04-11       Impact factor: 4.460

Review 2.  Progress of statistical analysis in biomedical research through the historical review of the development of the Framingham score.

Authors:  Aleksandra Ignjatović; Miodrag Stojanović; Zoran Milošević; Marija Anđelković Apostolović
Journal:  Ir J Med Sci       Date:  2017-12-02       Impact factor: 1.568

3.  Chronic kidney disease progression is mainly associated with non-recovery of acute kidney injury.

Authors:  Eric D'hoore; Nathalie Neirynck; Eva Schepers; Raymond Vanholder; Francis Verbeke; Mira Van Thielen; Wim Van Biesen
Journal:  J Nephrol       Date:  2015-02-21       Impact factor: 3.902

4.  Development and validation of a model to predict 5-year risk of death without ESRD among older adults with CKD.

Authors:  Nisha Bansal; Ronit Katz; Ian H De Boer; Carmen A Peralta; Linda F Fried; David S Siscovick; Dena E Rifkin; Calvin Hirsch; Steven R Cummings; Tamara B Harris; Stephen B Kritchevsky; Mark J Sarnak; Michael G Shlipak; Joachim H Ix
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-20       Impact factor: 8.237

5.  A Graphical Toolkit for Longitudinal Dataset Maintenance and Predictive Model Training in Health Care.

Authors:  Eric Bai; Sophia L Song; Hamish S F Fraser; Megan L Ranney
Journal:  Appl Clin Inform       Date:  2022-02-16       Impact factor: 2.342

Review 6.  Clinical Prediction Models for Cardiovascular Disease: Tufts Predictive Analytics and Comparative Effectiveness Clinical Prediction Model Database.

Authors:  Benjamin S Wessler; Lana Lai Yh; Whitney Kramer; Michael Cangelosi; Gowri Raman; Jennifer S Lutz; David M Kent
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-07-07

7.  Systematic review of predictive risk models for adverse drug events in hospitalized patients.

Authors:  Nazanin Falconer; Michael Barras; Neil Cottrell
Journal:  Br J Clin Pharmacol       Date:  2018-02-22       Impact factor: 4.335

8.  Validation of the D: A: D Chronic Kidney Disease Risk Score Model Among People Living With HIV in the Asia-Pacific.

Authors:  Win Min Han; Rimke Bijker; Ezhilarasi Chandrasekaran; Sanjay Pujari; Oon Tek Ng; Penh Sun Ly; Man-Po Lee; Kinh Van Nguyen; Yu-Jiun Chan; Cuong Duy Do; Jun Yong Choi; Romanee Chaiwarith; Tuti Parwati Merati; Sasisopin Kiertiburanakul; Iskandar Azwa; Suwimon Khusuwan; Fujie Zhang; Yasmin Mohamed Gani; Junko Tanuma; Shashikala Sangle; Rossana Ditangco; Evy Yunihastuti; Jeremy Ross; Anchalee Avihingsanon
Journal:  J Acquir Immune Defic Syndr       Date:  2020-12-01       Impact factor: 3.771

9.  Participatory design of probability-based decision support tools for in-hospital nurses.

Authors:  Alvin D Jeffery; Laurie L Novak; Betsy Kennedy; Mary S Dietrich; Lorraine C Mion
Journal:  J Am Med Inform Assoc       Date:  2017-11-01       Impact factor: 4.497

10.  Access to treatment for chronic kidney disease by children and adolescents in Brazil.

Authors:  Isabel de Pádua Paz; Tulio Konstantyner; Ricardo de Castro Cintra Sesso; Cristine Campos de Xavier Pinto; Maria Fernanda Carvalho de Camargo; Paulo Cesar Koch Nogueira
Journal:  Pediatr Nephrol       Date:  2021-03-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.